期刊
VACCINE
卷 36, 期 28, 页码 4134-4141出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2018.04.083
关键词
Retinoic acid; alpha 4 beta 7; CCR9; Gut mucosa; Vaccines
资金
- Bill and Melinda Gates Foundation [OPP1043696]
- Bill and Melinda Gates Foundation [OPP1043696] Funding Source: Bill and Melinda Gates Foundation
All-trans retinoic acid (ATRA) up-regulates, in laboratory animals, the expression of the gut homing markers alpha 4 beta 7 integrin and CCR9 on lymphocytes, increasing their gut tropism. Here, we show that, in healthy adult volunteers, ATRA induced an increase of these gut homing markers on T cells in vivo in a time dependent manner. The coordinated increase of alpha 4 beta 7 and CCR9 by ATRA was seen in 57% (12/21) of volunteers and only when given together with an oral Vivotif vaccine. When this coordinated response to ATRA and Vivotif vaccine was present, it was strongly correlated with the gut immunoglobulin A (IgA) specific response to vaccine LPS (p = 0.82: P = 0.02). Using RNA-Seq analysis of whole blood transcription, patients receiving ATRA and Vivotif in conjunction showed transcriptomic changes in immune-related pathways, particularly including interferon alpha/beta signaling pathway, membrane-ECM interactions and immune hubs. These results suggest that exogenous ATRA can be used to manipulate responses to a subclass of oral vaccines, so far limited to a live attenuated Vivotif vaccine. (C) 2018 The Authors. Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据